Watson Pharmaceuticals, Inc. (WPI) Tops Q1 EPS by 4c; Guides FY12 Sales
Tweet
Share
E-mailGet Alerts WPI Hot Sheet
Join SI Premium – FREE
Watson Pharmaceuticals, Inc. (NYSE: WPI) reported Q1 EPS of $1.64, $0.04 better than the analyst estimate of $1.60. Revenue for the quarter came in at $1.52 million versus the consensus estimate of $1.48 million.
Sees FY12 sales of $5.5 billion, versus the consensus of $5.5 billion.
For earnings history and earnings-related data on Watson Pharmaceuticals, Inc. (WPI) click here.
Sees FY12 sales of $5.5 billion, versus the consensus of $5.5 billion.
For earnings history and earnings-related data on Watson Pharmaceuticals, Inc. (WPI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Advance Auto Parts (AAP) Tops Q2 EPS by 22c; lifrs profit guidance
- BMO starts chip stocks coverage: Here are its preferred picks
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
